For research use only. Not for therapeutic Use.
IMAB027（Cat No.:I042189）is an investigational monoclonal antibody targeting the protein HER2 (human epidermal growth factor receptor 2), which is overexpressed in certain cancers, particularly breast and gastric cancers. HER2 is involved in tumor growth and survival, and by binding to it, IMAB027 aims to block the signaling pathways that promote cancer cell proliferation. Additionally, IMAB027 may enhance immune-mediated tumor destruction. It is being studied in clinical trials for its potential to treat HER2-positive cancers, with a focus on evaluating its safety, efficacy, and effectiveness in combination with other cancer therapies.
| Catalog Number | I042189 |
| CAS Number | 1650599-68-0 |
| Purity | ≥95% |
